BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 2, 2015
View Archived Issues
Cantargia licenses use of BioWa's Potelligent platform to produce CAN-04
Read More
Investigators develop and characterize a novel series of anticoronavirus agents
Read More
Immunocore and Lilly collaborate to study immunotherapies for melanoma
Read More
Actelion and Max Planck Society form new start-up Vaxxilon
Read More
Amarna Therapeutics partners with CBmed on development of immunotherapies
Read More
Taisho and Ablynx sign exclusive license agreement for ozoralizumab in Japan
Read More
Herantis Pharma granted European government loan for Parkinson's study
Read More
Safety board recommends phase III rindopepimut study continue
Read More
Scientists disclose phase I results for PepCan
Read More
Clinical endpoints met in phase II study of P2B-001 in early Parkinson's disease
Read More
MK-1439A enters two new phase III studies in HIV
Read More
Preclinical data of SIRM antibody support further development
Read More
KBP-089: an antiobesity dual amylin and calcitonin receptor agonist
Read More
AMAG to acquire Cord Blood Registry
Read More
Entasis debuts with a portfolio of drug candidates to treat drug-resistant infections
Read More
Teva and Xenon provide update on TV-45070 phase IIb study in osteoarthritis pain
Read More
GlaxoSmithKline presents phase Ib results of GSK-2256098
Read More
Panther Biotechnology to acquire Alchemia Oncology
Read More
Results from metformin arm of phase II trial of BI-187004
Read More
Sun Biomedical reports conditions met for acquisition of Dimerix
Read More
Allergan discloses S1P1 receptor modulators
Read More
Genentech presents ERK inhibitors
Read More
Ignyta's new clinical trial assay to support STARTRK program for entrectinib
Read More
Prolong's novel ANF compound for hematopoiesis deficiencies
Read More
Biogen and Sunesis patent BTK inhibitors
Read More
FDA extends review of cobimetinib NDA
Read More
Gilead submits NDA for emtricitabine/rilpivirine/tenofovir alafenamide in HIV
Read More